Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Evan Levine Insider Profile
4 Followers
Evan Levine, Chief Executive Officer at PsyBio Therapeutics, holds 5.10M shares in PsyBio Therapeutics (Ticker: TSE:PSYB.H). Most recently, Evan Levine Bought C$5,098,042 shares of PsyBio Therapeutics on Jan 13, 2023 for an estimated value of 254.90K.
Evan Levine has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
Chief Executive Officer
Roles that Evan Levine holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Evan Levine
Evan Levine's Trading History
List of latest transactions for each holding click on a transaction to see Evan Levine's performance on stock
You May Also Like
Evan Levine insider profile FAQ
What is the percentage of profitable transactions made by Evan Levine?
The percentage of profitable transactions made by Evan Levine is ―.
What is the average return per transaction made by Evan Levine?
The average return per transaction made by Evan Levine is ―.
What stocks does Evan Levine hold?
Evan Levine holds: TSE:PSYB.H stocks.
What was Evan Levine’s latest transaction?
Evan Levine latest transaction was an Informative Buy of C$254.90K.
What was Evan Levine's most profitable transaction?
Evan Levine’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Evan Levine's role in PsyBio Therapeutics?
Evan Levine's role in PsyBio Therapeutics is Chief Executive Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.